Skip to content

Monte Rosa Therapeutics, Inc. (GLUE) Insider Trading -- Recent Executive & Director Transactions

9 insiders reported 64 Form 4 transactions for Monte Rosa Therapeutics, Inc. (GLUE) over the past 18 months (most recent 2026-10-06). Recent activity: Bowen Matthew (Principal Accounting Officer) Sell 13 shares, Warmuth Markus (President & CEO) Sell 9,500 shares, Champoux Jennifer (Chief Operating Officer) Buy 4,351 shares, Champoux Jennifer (Chief Operating Officer) Sell 4,351 shares, Townson Sharon (Chief Scientific Officer) Buy 6,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-10-06Bowen MatthewPrincipal Accounting OfficerSell13$137
2026-07-17Warmuth MarkusPresident & CEOSell9,500$220,219
2026-07-16Champoux JenniferChief Operating OfficerBuy4,351$17,317
2026-07-16Champoux JenniferChief Operating OfficerSell4,351$101,730
2026-07-07Townson SharonChief Scientific OfficerBuy6,000$36,840
2026-07-07Townson SharonChief Scientific OfficerSell5,600$130,197
2026-07-07Townson SharonChief Scientific OfficerSell400$9,652
2026-07-06Behbahani AliDirectorSell1.0M$0
2026-07-06Behbahani AliDirectorBuy15,000$0
2026-07-06Behbahani AliDirectorSell15,000$0
2026-07-01Janku FilipChief Medical OfficerBuy5,407$72,508
2026-07-01Janku FilipChief Medical OfficerSell5,407$132,472
2026-06-30Manning Anthony M.DirectorBuy10,000$41,600
2026-06-30Manning Anthony M.DirectorSell10,000$231,100
2026-06-30Janku FilipChief Medical OfficerBuy6,000$45,360
2026-06-30Janku FilipChief Medical OfficerSell6,000$137,700
2026-06-25Champoux JenniferChief Operating OfficerBuy2,175$8,656
2026-06-25Champoux JenniferChief Operating OfficerSell2,175$43,500
2026-06-25Townson SharonChief Scientific OfficerBuy3,000$18,420
2026-06-25Janku FilipChief Medical OfficerBuy6,000$45,360
2026-06-25Janku FilipChief Medical OfficerSell11,845$239,506
2026-06-25Janku FilipChief Medical OfficerBuy30,000$226,800
2026-06-25Janku FilipChief Medical OfficerSell30,000$642,600
2026-06-25Townson SharonChief Scientific OfficerSell3,000$60,000
2026-06-18Champoux JenniferChief Operating OfficerBuy2,176$8,660

Source: SEC Form 4 filings · as of 2026-10-06